or
forgot password
  • cancer clinical trials in baltimore, MD

  • Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Greater Baltimore Medical Center
    Baltimore, Maryland 21204
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    St. Agnes Hospital Cancer Center
    Breast Cancer
    A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer
    Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center
    Baltimore, Maryland 21205
    Prostate Cancer
    Selumetinib in Treating Patients With Multiple Myeloma
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Refractory Multiple Myeloma
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    Veterans Affairs Medical Center - Baltimore

    Trial Locations
    Veterans Affairs Medical Center - Baltimore
    Greenebaum Cancer Center at University of Maryland Medical Center
    Malignant Mesothelioma
    Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231
    Squamous Cell Carcinoma of Oropharynx
    Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Metastatic Pancreatic Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland Greenebaum Cancer Center
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Mercy Medical Center
    University of Maryland Greenebaum Cancer Center
    Breast Cancer
    Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
    Johns Hopkins University
    Baltimore, Maryland 21205
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    A Study of Alpharadin® With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
    Johns Hopkins University
    Baltimore, Maryland 21205
    Bone Metastases, Castration-Resistant Prostate Cancer
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland, Greenbaum Cancer Center
    Chronic GVHD
    Trial Of Cisplatin And KML-001 In Advanced Non-Small Cell Lung Cancer and Other Platinum Responsive Malignancies
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Platinum Responsive Malignancies
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    University of Maryland
    Baltimore, Maryland 21201
    Peripheral T-cell Lymphoma
    Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland Greenebaum Cancer Center
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Ovarian Endometrioid Adenocarcinoma, Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Triple-negative Breast Cancer
    EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Baltimore, Maryland 21215
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
    Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Solid Tumor Malignancies
    Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
    Johns Hopkins Medicine
    Baltimore, Maryland 21287
    Melanoma
    Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Breast Cancer, Neoplasm Metastasis
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    The Johns Hopkins School of Medicine
    Baltimore, Maryland 21205
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Veterans Affairs Medical Center - Baltimore

    Trial Locations
    Veterans Affairs Medical Center - Baltimore
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
    Adult Brain Tumor Consortium
    Baltimore, Maryland 21231-1000
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Greenebaum Cancer Center at University of Maryland Medical Center
    Breast Cancer
    Study of Denileukin Diftitox in Patients With Stage IIIC and Stage IV Melanoma
    Weinberg Cancer Institution at Franklin Square
    Baltimore, Maryland 21237
    Stage IIIC Melanoma, Stage IV Melanoma
    Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland Greenebaum Cancer Center
    Acute Leukemias of Ambiguous Lineage, Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Franklin Square Hospital Center

    Trial Locations
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    ZOSTAVAX® in Renal Transplant Patients
    University of Maryland Baltimore - School of Medicine - Medicine
    Baltimore, Maryland 21201
    Herpes Zoster
    Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
    Johns Hopkins School of Medicine

    Trial Locations
    Johns Hopkins School of Medicine
    Johns Hopkins University School of Medicine
    Acromegaly
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Greater Baltimore Medical Center Cancer Center
    Baltimore, Maryland 21204
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Veliparib and Temozolomide in Treating Patients With Acute Leukemia
    Johns Hopkins University
    Baltimore, Maryland 21205
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), B-cell Adult Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
    Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
    Investigational Site Number 840019
    Baltimore, Maryland 21201
    Neoplasm Malignant
    Autologous Transplant in HIV Patients (BMT CTN 0803)
    Johns Hopkins Medical Institution

    Trial Locations
    Johns Hopkins Medical Institution
    University of Maryland Medical Systems, Greenebaum Cancer Center
    Lymphoma, HIV
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Trial Locations
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greenebaum Cancer Center at University of Maryland Medical Center
    Leukemia